HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab
These results suggest that [<sup>52</sup>Mn]Mn-DOTAGA(anhydride)-trastuzumab demonstrates efficient tumor-to-background contrast, emphasize the higher tumor uptake observed in orthotopic tumors, and highlight the influence of tumor environment characteristics on uptake.
Authors
- Csaba Csikos (ORCID: https://orcid.org/0000-0003-3338-340X)
- Zoltán Szoboszlai (ORCID: https://orcid.org/0000-0001-8228-4075)
- G. Nagy (ORCID: https://orcid.org/0000-0002-2131-0476)
- Gyula Tircsó (ORCID: https://orcid.org/0000-0002-7896-7890)
- Adrienn Vágner (ORCID: https://orcid.org/0000-0001-8566-0363)
- Tamás Nagy (ORCID: https://orcid.org/0000-0002-8158-4938)
- Balázs Váradi
- György Trencsényi (ORCID: https://orcid.org/0000-0001-6456-6212)
- Gábor Ország
- Toàn Minh Ngô
- Ildikó Garai
Institutions
- University of Debrecen (HU)
Publication Details
- Journal
- Pathology & Oncology Research
- Published
- 2025-04-29
- DOI
- https://doi.org/10.3389/pore.2025.1611999
- Citations
- 2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09